Quest Diagnostics Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Quest Diagnostics Inc (DGX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $21.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2016-02-26
- Quest Diagnostics Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was $21.00M, a 61.54% increase from fiscal 2014.
- Quest Diagnostics Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $13.00M, a 59.38% decline from fiscal 2013.
- Quest Diagnostics Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was $32.00M, a 28.89% decline from fiscal 2012.
- Quest Diagnostics Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2012 was $45.00M, a 4.65% increase from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2015-12-31 | $21.00M 10-K · filed 2016-02-26 |
| 2014-12-31 | $13.00M 10-K · filed 2016-02-26 |
| 2013-12-31 | $32.00M 10-K · filed 2016-02-26 |
| 2012-12-31 | $45.00M 10-K · filed 2015-02-24 |
| 2011-12-31 | $43.00M 10-K · filed 2014-02-18 |
| 2010-12-31 | $22.00M 10-K · filed 2013-02-27 |
| 2009-12-31 | $44.00M 10-K · filed 2012-02-16 |
| 2008-12-31 | $20.00M 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |